SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-009863
Filing Date
2019-02-25
Accepted
2019-02-25 16:23:02
Documents
5
Period of Report
2019-02-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv511286_6k.htm 6-K 13870
2 EXHIBIT 99.1 tv511286_ex99-1.htm EX-99.1 17637
3 EXHIBIT 99.2 tv511286_ex99-2.htm EX-99.2 844404
4 EXHIBIT 99.3 tv511286_ex99-3.htm EX-99.3 76564
5 EXHIBIT 99.4 tv511286_ex99-4.htm EX-99.4 66057
  Complete submission text file 0001144204-19-009863.txt   1019593
Mailing Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5
Business Address 1000 DE LA GAUCHETIERE STREET WEST SUITE 1200 MONTREAL A8 H3B 4W5 (514) 940-3600
Clementia Pharmaceuticals Inc. (Filer) CIK: 0001647320 (see all company filings)

IRS No.: 981128564 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38177 | Film No.: 19629797
SIC: 2834 Pharmaceutical Preparations